MNDRMobile-health Network Solutions同业对比
Mobile-health Network Solutions 与Services-Prepackaged Software的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Services-Prepackaged Software)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MNDR本股 | $1M#7 | — | 0.2x#1 | 0.2x#1 | -45.3%#12 | 78.3%#3 | -44.5%#10 | -40.6%#10 | — | — | -93.7%#12 | — |
| LIVG | — | — | — | — | -91.0%#14 | -1965.7%#14 | -9196.8%#15 | -28.1%#8 | — | — | — | — |
| LSPD | $1.4B#3 | — | — | 1.3x#2 | 18.4%#5 | -306.9%#13 | -64.6%#11 | — | — | — | -25.0%#5 | — |
| LTESF | — | — | — | — | -98.6%#15 | -4294.0%#15 | -7643.4%#14 | — | — | — | — | — |
| MAPS | — | — | — | — | -5.3%#8 | -74.3%#10 | 0.4%#4 | 3.1%#4 | — | — | -70.7%#11 | — |
| MCHX | — | — | — | — | -5.6%#9 | -5.8%#7 | -12.6%#8 | -18.0%#7 | -26.4%#3 | — | -30.1%#6 | — |
| MFON | — | — | — | — | 7.1%#6 | 15.2%#5 | -623.2%#13 | — | — | 4#1 | — | — |
| MKTW | — | 20.4x#3 | — | — | -19.7%#11 | -20.4%#9 | 19.1%#2 | — | — | — | 6.6%#4 | — |
| MNDY | $4.6B#1 | 40.4x#4 | 3.7x#3 | 3.8x#5 | 26.7%#3 | 266.8%#2 | -0.1%#5 | 9.5%#3 | — | — | -51.9%#10 | — |
| MOMO | — | 14.4x#1 | — | — | 2.4%#7 | -19.0%#8 | 13.1%#3 | 11.1%#2 | 69.8%#1 | — | -36.6%#8 | — |
| MQ | $1.7B#2 | — | 2.4x#2 | 2.7x#4 | 23.3%#4 | -151.0%#12 | -7.4%#6 | -1.9%#5 | — | — | -31.6%#7 | — |
| MSGM | $24M#6 | 15.5x#2 | 6.1x#4 | 2.1x#3 | 30.0%#2 | 351.7%#1 | 28.8%#1 | 178.3%#1 | — | — | 67.8%#2 | — |
| MTC | $645M#4 | — | 49.8x#5 | 799.2x#6 | -56.8%#13 | 38.5%#4 | -470.9%#12 | -432.6%#11 | -58.1%#4 | — | 641.6%#1 | — |
| MTLS | $457M#5 | — | — | — | — | — | — | — | — | — | 48.7%#3 | — |
| MYPS | — | — | — | — | -18.8%#10 | 0.2%#6 | -10.2%#7 | -13.8%#6 | — | — | -49.3%#9 | — |
| NAVN | — | — | — | — | 30.8%#1 | -119.8%#11 | -28.0%#9 | -30.3%#9 | -25.0%#2 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议